1. Home
  2. MPV vs NERV Comparison

MPV vs NERV Comparison

Compare MPV & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barings Participation Investors

MPV

Barings Participation Investors

HOLD

Current Price

$16.32

Market Cap

182.5M

Sector

Finance

ML Signal

HOLD

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.56

Market Cap

210.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPV
NERV
Founded
1988
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
182.5M
210.1M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
MPV
NERV
Price
$16.32
$4.56
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
24.3K
136.4K
Earning Date
01-01-0001
05-01-2026
Dividend Yield
8.71%
N/A
EPS Growth
N/A
N/A
EPS
1.71
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.05
$1.93
52 Week High
$21.00
$12.46

Technical Indicators

Market Signals
Indicator
MPV
NERV
Relative Strength Index (RSI) 51.33 52.73
Support Level $16.04 $3.81
Resistance Level $17.57 $4.61
Average True Range (ATR) 0.26 0.35
MACD 0.04 0.03
Stochastic Oscillator 69.33 65.79

Price Performance

Historical Comparison
MPV
NERV

About MPV Barings Participation Investors

Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: